Mirdametinib
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Mirdametinib, covering 2024-07-09 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma [Phase 1, Phase 2]